Kelly Frasier

Kelly Frasier


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2024 in JEADV Clinical Practice
Verified
Journal Article
Open access
KFKelly Frasier
Kelly Frasier
VLVivian Li
Vivian Li
MSMichelle Sobotka
Michelle Sobotka
JVJulia Vinagolu‐Baur
Julia Vinagolu‐Baur
GHGrace Herrick
Grace Herrick
The integration of wearable technology in real‐time skin health monitoring represents a significant advancement in personalised healthcare. This review synthesises existing research on wearable devices tailored for skin condition monitoring, encompassing aspects such as ultraviolet exposure tracking, hydration level assessment, and early detection of potential dermatological diseases. Current literature underscores the efficacy of wearable sensors in providing timely insights into skin health parameters, enabling proactive skin care interventions and disease management. Moreover, the seamless integration of sensor data with smartphone applications facilitates user‐friendly monitoring and personalised alerts, enhancing user engagement and adherence to skincare regimens. Moving forward, future research should prioritise the refinement of sensor accuracy and reliability, the development of standardised metrics for skin health assessment, and the exploration of novel applications such as artificial intelligence‐driven predictive analytics for early disease detection. Additionally, interdisciplinary collaborations between engineers, dermatologists, and data scientists hold promise for unlocking the full potential of wearable technology in revolutionising skin health management. Incorporating wearable technology in real‐time skin health monitoring not only revolutionises preventive skincare practices but also holds immense potential for transforming the management of chronic skin conditions, paving the way for personalised, proactive, and patient‐centric dermatological care.

18 April 2025 in Cureus
Verified
Journal Article
Open access
PDF file
MHMary Grace Hash
Mary Grace Hash
AFAlyssa Forsyth
Alyssa Forsyth
BCBret-Ashleigh Coleman
Bret-Ashleigh Coleman
VLVivian Li
Vivian Li
JVJulia Vinagolu-Baur
Julia Vinagolu-Baur
KFKelly Frasier
Kelly Frasier
Artificial intelligence (AI) is revolutionizing multiple industries, including health care and cosmetics, with particular promise in personalized skincare. This literature review explores recent advancements in AI technology that enable the development of highly customized skincare regimens. By integrating intrinsic factors such as skin type, pigmentation, texture, and genetic predispositions with external influences such as product ingredients, lifestyle choices, and environmental conditions, AI offers a sophisticated approach to managing skin health. AI’s ability to analyze and synthesize vast amounts of data allows for a more comprehensive understanding of how these factors interact, facilitating the prediction of long-term skin health outcomes with greater accuracy. Moreover, AI-driven innovations enable the creation of dynamic, adaptive skincare routines that adjust in real-time to physiological changes and external conditions, ensuring a personalized treatment that evolves with each individual’s dermatological needs. As AI technology advances, its role in skincare is expected to deliver increasingly personalized and effective therapies, shifting from traditional, static skincare approaches to a more dynamic paradigm. This transformation holds great promise for improving dermatological outcomes and enhancing patient satisfaction through tailored real-time skincare management.

17 April 2025 in Cureus
Verified
Journal Article
Open access
PDF file
KMKaitlyn Miner
Kaitlyn Miner
RMRyan Murphy
Ryan Murphy
SSSamantha Steiss
Samantha Steiss
MBMcKenzie Burian
McKenzie Burian
HWHannah Welp
Hannah Welp
KFKelly Frasier
Kelly Frasier
Lipid dysregulation within sebaceous glands is a critical factor underlying the pathogenesis of sebaceous gland disorders, particularly acne vulgaris. Sebaceous glands synthesize and secrete a complex mixture of lipids, including triglycerides, wax esters, free fatty acids, and sphingolipids, which contribute to skin barrier function and microbial homeostasis. Dysregulated lipid production, characterized by increased sebum secretion and altered lipid composition, has been implicated in promoting Cutibacterium acnes proliferation, hyperkeratinization, and inflammation, key processes in acne pathogenesis. Recent research highlights the pivotal role of sphingolipid metabolism, particularly ceramides, in modulating sebaceous gland activity and skin inflammation. Ceramide deficiencies in acne-prone skin contribute to compromised barrier integrity, increased microbial colonization, and an exaggerated inflammatory response. Furthermore, sphingolipid intermediates such as sphingosine-1-phosphate (S1P) influence sebocyte differentiation, lipid synthesis, and cytokine release, linking sphingolipid metabolism to sebaceous gland homeostasis. Emerging therapeutic strategies targeting sphingolipid pathways offer new opportunities for managing sebaceous gland disorders. Topical and systemic therapies designed to restore ceramide levels and modulate S1P signaling have shown promise in preclinical studies, with potential to reduce sebum production, enhance barrier function, and attenuate inflammation. Additionally, sphingolipid-targeted formulations combined with established treatments, such as retinoids and antimicrobial agents, may enhance therapeutic outcomes while minimizing side effects. The dysregulation of sebaceous lipid metabolism, particularly sphingolipid pathways, plays a central role in acne pathogenesis, and emerging insights into these mechanisms are shaping innovative strategies for the treatment and prevention of sebaceous gland disorders.

16 October 2024 in Cureus
Verified
Journal Article
Open access
KFKelly Frasier
Kelly Frasier
HFHaily A Fritts
Haily A Fritts
VLVivian Li
Vivian Li
CDChristina Dudzik
Christina Dudzik
MSMichelle Sobotka
Michelle Sobotka
ALAlexandra Loperfito
Alexandra Loperfito
This comprehensive review critically examines the complex relationship between Munchausen Syndrome by Proxy (MSBP) and its dermatological manifestations, uncovering new insights into the relatively uncharted territory of this psychiatric disorder. By synthesizing existing literature, case studies, and clinical observations, this paper reveals the multifaceted spectrum of dermatological phenomena seen in individuals affected by MSBP, ranging from self-inflicted injuries to entirely fabricated skin conditions. Additionally, we explore the psychological and behavioral mechanisms driving caregivers to induce or stimulate dermatological symptoms, shedding light on underlying psychopathologies, the nuanced dynamics of the caregiver-patient relationship, and patterns of pathological attachment and dependency. This review confronts the significant obstacles healthcare providers encounter in accurately identifying dermatological symptoms related to MSBP amidst genuine dermatologic conditions, underscoring the indispensable role of a multidisciplinary strategy and heightened clinical vigilance in these complex cases. Future investigations call for the development of standardized assessment tools, the potential of biomarkers for early detection, the exploration of the neurobiological basis of MSBP, and the utilization of specific interventions to protect susceptible populations while improving the accuracy of MSBP diagnoses. This paper calls for a more informed, sensitive, and proactive approach to better understanding and treating the dermatological manifestations of MSBP.

15 January 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
KFKelly Frasier
Kelly Frasier
NWNicole Werpachowski
Nicole Werpachowski
MHMary Grace Hash
Mary Grace Hash
RMRaman Madan
Raman Madan

4 November 2024 in Cureus
Verified
Journal Article
Open access
PDF file
KFKelly Frasier
Kelly Frasier
GHGrace Herrick
Grace Herrick
HPHiral Patel
Hiral Patel
SKSriya Kakarla
Sriya Kakarla
LDLana Danial
Lana Danial
NPNiralee R. Patel
Niralee R. Patel
Retention in dermatological clinical trials is critical for ensuring the validity and reliability of study outcomes, yet participant dropout remains a pervasive challenge. In this analysis, the primary aim is to explore the psychological mechanisms underpinning the efficacy of a buddy system in enhancing retention rates in such trials. The buddy system, where participants are paired with peers who have previously participated in similar clinical trials offers mutual support and leverages the principles of social bonding, accountability, and shared experience to foster commitment and reduce attrition. The novelty of this approach lies in its focus on the psychological and emotional dimensions of trial participation, rather than solely on logistical or incentive-based strategies. Implementing a buddy system draws on theories of social support and motivation, suggesting that the presence of a buddy can alleviate anxiety, increase perceived value, and enhance the overall clinical trial experience. Future research should investigate the long-term effects of buddy systems across diverse demographic groups and dermatological conditions, as well as potential adaptations for virtual trial settings. In conclusion, integrating a buddy system into dermatological clinical trials represents an innovative strategy that could significantly improve retention, thereby strengthening the robustness of clinical data and advancing dermatological research.